Dimerix Successfully Completes Recruitment for Phase 3 ACTION3 Trial of DMX-200 Dimerix Limited has successfully completed recruitment for its Phase 3 trial of DMX-200 in patients with FSGS, marking a significant milestone in kidney disease treatment.

Dimerix Successfully Completes Recruitment for Phase 3 ACTION3 Trial of DMX-200 #Australia #Melbourne #FSGS #Dimerix #DMX-200

Weekly Roundup - PHARMA - 13 January 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/pharma-news

#ANIPharmaceuticals #Prucalopride #Motegrity #Dimerix #Fuso #DMX200 #FSGS #MeijiSeikaPharma #MPMBioImpact #ClinicalTrials #Humanteconomy #Humantec #KStrategyand